Growth Investors & VC Firms in Spain

35 firms in this list, with a median first check of $540K. 5 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
IN Inveready Technology Investment Group AMBFRGAB58 people	88🔒	Spain	ES	Pre-Seed–Late Stage	$108K – $21.6M	+ Add to CRM
NE Nexxus Capital AGAASRL59 people	88🔒	Mexico City	MX	Growth	—	+ Add to CRM
EL Elaia ACEPFDMR11 people	88🔒	Paris	FR	Seed–Growth	$108K – $1.6M	+ Add to CRM
EN Encomenda VC JDMTJWCB22 people	88🔒	Barcelona	ES	Pre-Seed–Growth	$100K – $500K	+ Add to CRM
RI Ribbit Capital MMBPCMJA12 people · Leads rounds	88🔒	Palo Alto	US	Seed–Growth	$100K – $15M	+ Add to CRM
KF Kfund CSGRIAJN20 people	88🔒	Madrid	ES	Pre-Seed–Growth	$115K – $11.5M	+ Add to CRM
GO Goodwater Capital CCEJCJJO9 people · Leads rounds	88🔒	Burlingame	US	Pre-Seed–Late Stage	$5M – $50M	+ Add to CRM
MO Motive Partners Leads rounds	88🔒	New York	US	Pre-Seed–Late Stage	$1M – $10M	+ Add to CRM
SW Swanlaab Venture Factory MKASCJJR9 people · Leads rounds	88🔒	Spain	ES	Seed–Growth	$540K – $3.2M	+ Add to CRM
PR Proeza Ventures EMREBGCG7 people · Leads rounds	88🔒	Houston	US	Pre-Seed–Growth	$500K – $2M	+ Add to CRM
DI Dila Capital CÁLLNJYS9 people	88🔒	Mexico City	MX	Seed–Growth	—	+ Add to CRM
DA Dawn Capital LLP DCEPHOHM11 people	88🔒	London	GB	Series A–Growth	$317.5K – $6.3M	+ Add to CRM
ET ETF Partners PSFBLRRD11 people	88🔒	London	GB	Series A–Growth	$5.4M – $16.2M	+ Add to CRM
FO Foresight Group PECADWDH11 people	88🔒	Sydney Nsw	GB	Seed–Late Stage	$1.3M – $6.3M	+ Add to CRM
GI Gilde Healthcare AFEDGPHD11 people	88🔒	Utrecht	NL	Seed–Late Stage	$1.1M – $32.4M	+ Add to CRM
IM IMPACT Partners ASAFGCSM11 people	88🔒	Paris	FR	Seed–Growth	$54K – $5.4M	+ Add to CRM
TA Talde Private Equity IBJAMBAM11 people	88🔒	Bilbao	ES	Growth	$5.4M – $16.2M	+ Add to CRM
SE Seaya BGAXCFJG8 people	88🔒	Madrid	ES	Seed–Late Stage	$2.2M – $16.2M	+ Add to CRM
EU Eurazeo AACMESEL11 people	88🔒	Paris	FR	Series A–Late Stage	—	+ Add to CRM
ED Edenred Ventures NFPDFCOB7 people	88🔒	London	GB	Seed–Growth	$540K – $5.4M	+ Add to CRM
MI Milano Investment Partners SGR AMPGAVIP10 people	88🔒	Milan	IT	Seed–Late Stage	—	+ Add to CRM
TE TEV Ventures CWHKJSMM9 people	88🔒	Essen	DE	Pre-Seed–Late Stage	$7.6M	+ Add to CRM
ED EDP Ventures FGABLFMC5 people	88🔒	Lisbon	PT	Seed–Growth	$1.1M – $10.8M	+ Add to CRM
FU Full In Partners EDETTPJL5 people	88🔒	New York	US	Growth	$3M – $50M	+ Add to CRM

Inveready Technology Investment Group

SpainPre-Seed–Late Stage$108K – $21.6M

AMBFRGAB58 people

Nexxus Capital

Mexico CityGrowth

AGAASRL59 people

Elaia

ParisSeed–Growth$108K – $1.6M

ACEPFDMR11 people

Encomenda VC

BarcelonaPre-Seed–Growth$100K – $500K

JDMTJWCB22 people

Ribbit Capital

Palo AltoSeed–Growth$100K – $15M

MMBPCMJA12 people

Kfund

MadridPre-Seed–Growth$115K – $11.5M

CSGRIAJN20 people

Goodwater Capital

BurlingamePre-Seed–Late Stage$5M – $50M

CCEJCJJO9 people

Motive Partners

New YorkPre-Seed–Late Stage$1M – $10M

Swanlaab Venture Factory

SpainSeed–Growth$540K – $3.2M

MKASCJJR9 people

Proeza Ventures

HoustonPre-Seed–Growth$500K – $2M

EMREBGCG7 people

Dila Capital

Mexico CitySeed–Growth

CÁLLNJYS9 people

Dawn Capital LLP

LondonSeries A–Growth$317.5K – $6.3M

DCEPHOHM11 people

ETF Partners

LondonSeries A–Growth$5.4M – $16.2M

PSFBLRRD11 people

Foresight Group

Sydney NswSeed–Late Stage$1.3M – $6.3M

PECADWDH11 people

Gilde Healthcare

UtrechtSeed–Late Stage$1.1M – $32.4M

AFEDGPHD11 people

IMPACT Partners

ParisSeed–Growth$54K – $5.4M

ASAFGCSM11 people

Talde Private Equity

BilbaoGrowth$5.4M – $16.2M

IBJAMBAM11 people

Seaya

MadridSeed–Late Stage$2.2M – $16.2M

BGAXCFJG8 people

Eurazeo

ParisSeries A–Late Stage

AACMESEL11 people

Edenred Ventures

LondonSeed–Growth$540K – $5.4M

NFPDFCOB7 people

Milano Investment Partners SGR

MilanSeed–Late Stage

AMPGAVIP10 people

TEV Ventures

EssenPre-Seed–Late Stage$7.6M

CWHKJSMM9 people

EDP Ventures

LisbonSeed–Growth$1.1M – $10.8M

FGABLFMC5 people

Full In Partners

New YorkGrowth$3M – $50M

EDETTPJL5 people

Data sourced from public filings and firms' own websites — see our methodology.